Article
Covid-19 vaccine: Large study supports third Pfizer jab for immunocompromised | Health24
Rating:
0.0
Views:
48
Likes:
1
Library:
1
A large study looking at breakthrough infections in immunocompromised people following two doses of the Pfizer vaccine suggests that this group may benefit from a third dose.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value